Dominik Maurer

Actively personalized vaccination trial for newly diagnosed glioblastoma

Norbert Hilf, Sabrina Kuttruff-Coqui, Katrin Frenzel et al. · Nature · 2018 · 897 citations

Vaccination, Neuro-oncology, Vaccination Trial +6

Multipeptide immune response to cancer vaccine IMA901 after single-dose cyclophosphamide associates with longer patient survival

Steffen Walter, Toni Weinschenk, Arnulf Stenzl et al. · Nature Medicine · 2012 · 777 citations · Full text

Vaccination, Cancer Immunosurveillance, Multipeptide Immune Response +12

IMA901, a multipeptide cancer vaccine, plus sunitinib versus sunitinib alone, as first-line therapy for advanced or metastatic renal cell carcinoma (IMPRINT): a multicentre, open-label, randomised, controlled, phase 3 trial

Brian I. Rini, Arnulf Stenzl, Romauld Zdrojowy et al. · The Lancet Oncology · 2016 · 211 citations

Sunitinib Versus Sunitinib, Urology, Genitourinary Cancer +8

Toward harmonized phenotyping of human myeloid-derived suppressor cells by flow cytometry: results from an interim study

Susanna Mandruzzato, Sven Brandau, Cedrik M. Britten et al. · Cancer Immunology Immunotherapy · 2016 · 196 citations · Full text

Activated human T lymphocytes express MHC class I heavy chains not associated with beta 2-microglobulin.

E Schnabl, Hannes Stockinger, Otto Majdic et al. · The Journal of Experimental Medicine · 1990 · 135 citations · Full text

Histocompatibility, Mhc Class, Hla Immunogenetics +19